Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system

Nature Medicine volume 18, pages 344–346 (2012)Cite this article

Subjects

To the Editor:

On the basis of data published in Nature Medicine, the research groups of Zitvogel and Kroemer have hypothesized that the adaptive immune system dictates the therapeutic efficacy of certain chemotherapeutics1,2,3. Using in vitro systems and tumor transplantation models, they showed that cancer cells undergo immunogenic cell death in response to certain commonly used chemotherapeutics, specifically anthracyclines and oxaliplatin1,2,3, which leads to activation of effective antitumor T cell responses1,2,3. Consistent with these observations, the authors showed that anthracyclines and oxaliplatin lose their therapeutic efficacy on tumor cell line outgrowths in mice with defective adaptive immune cell function1,2,3.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Chemotherapy efficacy in tumor-bearing MMTV-NeuT mice is independent of the adaptive immune system.
Figure 2: Chemotherapy efficacy in tumor-bearing K14cre; Cdh1flox/flox; Trp53flox/flox mice is independent of the adaptive immune system.

References

  1. Apetoh, L. et al. Nat. Med. 13, 1050–1059 (2007).

    Article  CAS  Google Scholar 

  2. Obeid, M. et al. Nat. Med. 13, 54–61 (2007).

    Article  CAS  Google Scholar 

  3. Ghiringhelli, F. et al. Nat. Med. 15, 1170–1178 (2009).

    Article  CAS  Google Scholar 

  4. Schreiber, K., Rowley, D.A., Riethmuller, G. & Schreiber, H. Hematol. Oncol. Clin. North Am. 20, 567–584 (2006).

    Article  Google Scholar 

  5. Mattarollo, S.R. et al. Cancer Res. 71, 4809–4820 (2011).

    Article  CAS  Google Scholar 

  6. Olive, K.P. et al. Science 324, 1457–1461 (2009).

    Article  CAS  Google Scholar 

  7. Willimsky, G. et al. J. Exp. Med. 205, 1687–1700 (2008).

    Article  CAS  Google Scholar 

  8. DeNardo, D.G. et al. Cancer Discov. 1, 54–67 (2011).

    Article  CAS  Google Scholar 

  9. Ramakrishnan, R. et al. J. Clin. Invest. 120, 1111–1124 (2010).

    Article  CAS  Google Scholar 

  10. Robert, C. et al. N. Engl. J. Med. 364, 2517–2526 (2011).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank T.N. Schumacher for helpful discussions. We thank the protein facility at the Netherlands Cancer Institute for providing the antibody against CD8. Research described in this Correspondence was supported by grants from the Dutch Cancer Society (KWF grants 2006-3715 and 2011-5004 to K.E.d.V. and J.J.), the Netherlands organization for Scientific Research (NWO grant VIDI 917.96.307 to K.E.d.V.) and the Association for International Cancer Research (AICR grant 11-0677 to K.E.d.V.).

Author information

Authors and Affiliations

  1. Division of Molecular Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands

    Metamia Ciampricotti, Cheei-Sing Hau, Chris W Doornebal, Jos Jonkers & Karin E de Visser

Authors
  1. Metamia Ciampricotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheei-Sing Hau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chris W Doornebal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jos Jonkers
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karin E de Visser
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.J. and K.E.d.V. designed the study. M.C., C.-S.H. and C.W.D. performed the experiments. K.E.d.V. took the initiative for this Correspondence and wrote the manuscript. All coauthors provided comments that helped shape the final submission.

Corresponding author

Correspondence to Karin E de Visser.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–3 and Supplementary Methods (PDF 189 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ciampricotti, M., Hau, CS., Doornebal, C. et al. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system. Nat Med 18, 344–346 (2012). https://doi.org/10.1038/nm.2652

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2652

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer